US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Drugs Made in America Acquisition Corp. II

10.20

0.0000

Volume:- -

Turnover:- -

Market Cap:668.86M

PE:75.69

High:10.20

Open:10.20

Low:10.20

Close:10.20

52wk High:10.80

52wk Low:9.94

Shares:65.58M

Float Shares:62.24M

Volume Ratio:- -

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):0.1348

ROE:--

ROA:-0.32%

PB:-37.31

PE(LYR):- -

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Drugs Made in America Acquisition II FY26 Q2 Net Income Turns to Profit at $4.4 Million

Drugs Made in America Acquisition II swings to Q1 FY26 net income of $4.34 million

Drugs Made in America Acquisition II posts FY25 net income of $4.2 million

Drugs Made in America Acquisition II issues $1.4 million convertible notes financing deal

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/DMIIU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"DMIIU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DMIIU\",,,,,undefined,":{"symbol":"DMIIU","market":"US","secType":"STK","nameCN":"Drugs Made in America Acquisition Corp. II","latestPrice":10.1999,"timestamp":1787342400000,"preClose":10.1999,"halted":0,"volume":0,"delay":0,"changeRate":0,"floatShares":62241691,"shares":65575000,"eps":0.13475977,"marketStatus":"Market Closed","change":0,"latestTime":"08-21 16:00:00 EDT","open":10.1999,"high":10.1999,"low":10.1999,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.13475977,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787558400000},"marketStatusCode":7,"adr":0,"listingDate":1758772800000,"exchange":"NASDAQ","adjPreClose":10.1999,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DMIIU\",,,,,undefined,":{"symbol":"DMIIU","floatShares":62241691,"roa":"-0.32%","roe":"--","lyrEps":0,"shares":65575000,"dividePrice":0,"high":10.1999,"amplitude":0,"preClose":10.1999,"low":10.1999,"week52Low":9.935,"pbRate":"-37.31","week52High":10.8,"institutionHeld":0,"latestPrice":10.1999,"eps":0.13475977,"divideRate":0,"volume":0,"delay":0,"ttmEps":0.13475977,"open":10.1999,"prevYearClose":10.015,"prevWeekClose":10.17,"prevMonthClose":10.16,"prevQuarterClose":10.16,"fiveDayClose":10.17,"twentyDayClose":10.16,"sixtyDayClose":10.11},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/DMIIU\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-14","symbol":"DMIIU","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1786680000000,"reportTimeType":"post","actualEps":null},{"date":"2026-05-14","symbol":"DMIIU","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1778788800000,"name":null,"time":"Post-Mkt","dateTimestamp":1778731200000,"actualEps":null},{"date":"2026-04-15","symbol":"DMIIU","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1776283200000,"name":null,"time":"Post-Mkt","dateTimestamp":1776225600000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"DMIIU\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"DMIIU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"DMIIU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2659129884","title":"Drugs Made in America Acquisition II FY26 Q2 Net Income Turns to Profit at $4.4 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2659129884","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659129884?lang=en_us&edition=fundamental","pubTime":"2026-08-15 04:11","pubTimestamp":1786738284,"startTime":"0","endTime":"0","summary":"Drugs Made in America Acquisition II FY26 Q2 net income turns to profit at $4.4 millionDrugs Made in America Acquisition II posted net income of $4.4 million for the quarter ended June 30, 2026.Genera","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nNDL764nkh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DMII","DMAA","DMIIU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635725101","title":"Drugs Made in America Acquisition II swings to Q1 FY26 net income of $4.34 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2635725101","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635725101?lang=en_us&edition=fundamental","pubTime":"2026-05-15 04:22","pubTimestamp":1778790161,"startTime":"0","endTime":"0","summary":"Drugs Made in America Acquisition II posted net income of USD 4.34 million for the quarter ended March 31, 2026, swinging from a net loss of USD 59,327 a year earlier.Interest earned on cash and investments held in the trust account totaled USD 4.44 million, while general and administrative costs were USD 132,030.Cash on hand was USD 347,720 at March 31, 2026, up from USD 223 at Dec. 31, 2025.Management said substantial doubt exists about its ability to continue as a going concern within one year, tied to completing an initial business combination within its 24-month window.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Drugs Made in America Acquisition II Corp. published the original content used to generate this news brief via EDGAR","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260514:nNDLcfh50g:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DMII","DMIIU","DMAA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627923779","title":"Drugs Made in America Acquisition II posts FY25 net income of $4.2 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2627923779","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627923779?lang=en_us&edition=fundamental","pubTime":"2026-04-16 04:11","pubTimestamp":1776283882,"startTime":"0","endTime":"0","summary":"Drugs Made in America Acquisition II posted net income of USD 4.2 million for fiscal 2025, driven by USD 4.9 million of interest earned on cash and investments held in the trust account.Revenue was not reported, as the SPAC had not generated operating revenues to date.General and administrative costs totaled USD 488,385, while a USD 812,113 provision for credit losses reflected a full reserve against amounts due from the sponsor.Management said conditions raised substantial doubt about its ability to continue as a going concern within one year after the financial statements are issued.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Drugs Made in America Acquisition II Corp. published the original content used to generate this news brie","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260415:nNDL3vSnT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DMIIU","DMII","DMAA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624968664","title":"Drugs Made in America Acquisition II issues $1.4 million convertible notes financing deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2624968664","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624968664?lang=en_us&edition=fundamental","pubTime":"2026-04-04 04:34","pubTimestamp":1775248467,"startTime":"0","endTime":"0","summary":"Drugs Made in America Acquisition II entered into a definitive investment agreement on March 24, 2026 for a contemplated convertible notes financing.Company issued an interim convertible note of USD 0.3 million on March 30, 2026 to Alpha Multi Family Office.Note matures nine months from issuance, carries no interest.Investor can convert principal at business combination into shares at 35% discount to market price at conversion.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Drugs Made in America Acquisition II Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 03, 2026, and is so","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260403:nNDLWvCKf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DMAA","DMIIU","DMII"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":2,"pageCount":1,"totalSize":8,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/DMIIU\",params:#limit:6,delay:false,,,undefined,":[]}}